ARTV EPS Estimates
Artiva Biotherapeutics, Inc.
$6.06
+$0.15(+2.54%)
35
Overall
60
Value
18
Tech
28
Quality
Market Cap
$288.94M
Volume
34.49K
52W Range
$2.71 - $14.53
Target Price
$35.80
ARTV EPS estimates: the consensus estimate for Artiva Biotherapeutics, Inc.'s current fiscal year is -$2.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ARTV EPS Estimates
- EPS estimate, current quarter
- $-0.54
- EPS estimate, next quarter
- $-0.62
- EPS estimate, current year
- $-2.62
- EPS estimate, next year
- $-2.79
- EPS growth, 3-year
- +64.50%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.43 |
| 2024 | $-5.81 |
| 2023 | $-35.78 |
| 2022 | $-76.67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARTV | $6.06 | +2.5% | 34.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Artiva Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW